Print

HVTN 101

Evaluating the Safety and Immune Response to Two HIV Vaccine Regimens in Healthy, HIV-Uninfected Adults in the United States and South Africa

Trial Details:

I Scheduled
HIV Vaccine Trials Network (HVTN), IPPOX, EuroVacc, Global Solutions for Infectious Diseases (GSID)
DNA-HIV-PT123,NYVAC-HIV-PT1,NYVAC-HIV-PT4,AIDSVAX B/E
DNA-HIV-PT123 DNA
NYVAC-HIV-PT1
AIDSVAX B/E Protein
USA 264
http://www.clinicaltrials.gov/ct2/show/NCT01927835?term=hvtn+101&rank=1